APA (7th ed.) Citation

J, H., Y, Z., X, Z., T, M., T, H., J, L., . . . J, W. (2020). Therapeutic efficacy and imaging assessment of the HER2-targeting chemotherapy drug ZHER2: V2-pemetrexed in lung adenocarcinoma Xenografts. Investigational new drugs, 38(4), 1031. https://doi.org/10.1007/s10637-019-00876-3

Chicago Style (17th ed.) Citation

J, Han, Zhao Y, Zhao X, Ma T, Hao T, Liu J, Zhang Z, Zhang J, and Wang J. "Therapeutic Efficacy and Imaging Assessment of the HER2-targeting Chemotherapy Drug ZHER2: V2-pemetrexed in Lung Adenocarcinoma Xenografts." Investigational New Drugs 38, no. 4 (2020): 1031. https://doi.org/10.1007/s10637-019-00876-3.

MLA (9th ed.) Citation

J, Han, et al. "Therapeutic Efficacy and Imaging Assessment of the HER2-targeting Chemotherapy Drug ZHER2: V2-pemetrexed in Lung Adenocarcinoma Xenografts." Investigational New Drugs, vol. 38, no. 4, 2020, p. 1031, https://doi.org/10.1007/s10637-019-00876-3.